STK25 inhibits cancer‐associated fibroblast activation to overcome cetuximab resistance in colorectal cancer.

Saved in:
Bibliographic Details
Title: STK25 inhibits cancer‐associated fibroblast activation to overcome cetuximab resistance in colorectal cancer.
Authors: Hou, Yifan1 (AUTHOR), Chen, Jiangbo1 (AUTHOR), Hao, Hao1 (AUTHOR), Song, Tongkun1 (AUTHOR), Song, Lin1 (AUTHOR), Xing, Pu1 (AUTHOR), Weng, Kai1 (AUTHOR), Ran, Yumeng1 (AUTHOR), Yang, Xinying1 (AUTHOR), Qiao, Xiaowen1 (AUTHOR), Chen, Jie2 (AUTHOR), Yao, Ruibin3 (AUTHOR), Yang, Hong1,4 (AUTHOR), Chen, Lei1 (AUTHOR), Di, Jiabo1 (AUTHOR), Xu, Kai1 (AUTHOR) xukai@bjmu.edu.cn, Su, Xiangqian1,5 (AUTHOR) suxiangqian@bjmu.edu.cn, Jiang, Beihai1 (AUTHOR) beihai_jiang@bjmu.edu.cn
Source: Clinical & Translational Medicine. May2026, Vol. 16 Issue 5, p1-21. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20011326
DOI:10.1002/ctm2.70678